The dysregulation of pathways such as EIF2 signaling and mTOR signaling has been implicated in various pathological conditions, including tumorigenesis, neurodegenerative diseases, and metabolic disorders [16,17]. This evidence concerns the gene MTOR and Other metabolic disease.